"","V1","V2","V3","V4","V5","V6","V7","V8","V9","V10","V11","V12","V13","V14","V15","V16","V17","V18","V19","V20","V21","V22","V23","V24","V25","V26","V27","V28","V29","V30","V31","V32","V33","V34","V35","V36","V37","V38","V39","V40","V41","V42","V43","V44","V45","V46","V47","V48","V49","V50","V51","V52","V53","V54","V55","V56","V57","V58","V59","V60","V61","V62","V63","V64","V65","V66","V67","V68","V69","V70","V71","V72","V73","V74","V75","V76","V77","V78","V79","V80","V81","V82","V83","V84","V85","V86","V87","V88","V89","V90","V91","V92","V93","V94","V95","V96","V97","V98","V99","V100","V101","V102","V103","V104","V105","V106","V107","V108","V109","V110","V111","V112","V113","V114","V115","V116","V117","V118","V119","V120","V121","V122","V123","V124","V125","V126","V127","V128","V129","V130","V131","V132","V133","V134","V135","V136","V137","V138","V139","V140","V141","V142","V143","V144","V145","V146","V147","V148","V149","V150","V151","V152","V153","V154","V155","V156","V157","V158"
"1","abs379.txt","objectives","","to","model","the","cost-effectiveness","of","a","biomarker-based","approach","toselect","patients","for","neoadjuvant","chemotherapy","(nac)","before","radical","cystectomy","(rc)in","muscle-invasive","bladder","cancer","(mibc)","and","methods","we","obtained","data","from","most","recent","clinical","studies","onpatients","with","locally","advanced","mibc","treated","by","rc","including","stage","distributions","overall","survival","(os)","estimates","associated","costs","utilisation/response","tonac","additionally","estimated","putative","efficacy","three","biomarkers","nac","dna-repair","gene","panel","[ataxia","telangiectasia","mutated(atm)","retinoblastoma","1","(rb1)","fanconi","anaemia","complementation","group","c(fancc)]","excision","repair","cross-complementation","2","(ercc2)","ribonucleicacid","(rna)","subtypes","decision","analysis","was","developed","evaluate","thecost-effectiveness","approaches","select","fornac","comparison","included","alone","unselected","plus","based","on","aforementioned","results","panel-based","mostcost-effective","strategy","(mean","os","3","14","years","$31","482/life","year)","under","thisapproach","38%","would","undergo","about","twice","number","who","arecurrently","receiving","such","an","improve","mean","5","6","4","months","compared","hypothetical","scenario","where","allpatients","received","current","utilisation","respectively","conclusions","identify","shouldundergo","more","cost-effective","than","use","or","asfurther","becomes","available","may","serve","as","basis","forincorporating","into","making"
